Literature DB >> 12830356

The development of an 18-locus Y-STR system for forensic casework.

Ashley Hall1, Jack Ballantyne.   

Abstract

The aim of the present work was to improve the discriminatory potential, and hence the probative value, of Y-STR-based testing by extending the set of Y chromosome STR loci available for forensic casework. In accordance with the requirements of a Y chromosome multiplex analytical system developed specifically for forensic casework use, we have sought to maximize the number of loci able to be co-amplified, ensure appropriate assay sensitivity (1-2 ng of input genomic DNA), balance inter-locus signals and minimize confounding female DNA artifacts. Two Y chromosome STR systems, multiplex I (MPI) and multiplex II (MPII), have been developed which permit the robust co-amplification of 18 Y-STRs. The loci include DYS19, DYS385(a) and (b), DYS388, DYS389I and II, DYS390, DYS391, DYS392, DYS393, DYS425, DYS434, DYS437, DYS438, DYS439, Y-GATA-C4, Y-GATA-A7.1 (DYS460) and Y-GATA-H4. The two multiplex systems are robust over a wide range of primer, magnesium, and DNA polymerase concentrations and perform well under a variety of cycling conditions. Complete male haplotypes can be obtained with as little as 100-250 pg of template DNA. Although a limited number of female DNA artifacts are observed in mixed stains in which the male DNA comprises 1/100 of the total, the male profile is easily discernible. Slightly modified versions of MPI and MPII demonstrate a significant reduction in female artifacts. Thus, it may not be necessary to employ a differential extraction strategy to obtain a male haplotype (or haplotypes in the case of multiple male donors) in cases of sexual assault. The potential utility of MPI and MPII for forensic casework is exemplified by their ability to dissect out the male haplotype in post-coital vaginal swabs and to determine the number of male donors in mixed semen stains. This study has emphasized the need for novel Y-STR multiplexes developed for forensic use to undergo a series of validation exercises that go beyond simply optimizing the PCR reaction conditions. Specifically, stringent performance checks on their efficacy need to be carried out using casework-type specimens in order to determine potential confounding effects from female DNA.

Entities:  

Mesh:

Year:  2003        PMID: 12830356     DOI: 10.1007/s00216-003-2039-2

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  6 in total

1.  Diversity of five novel Y-STR loci and their application in studies of north Chinese populations.

Authors:  Zhaoyang Xu; Haiming Sun; Yang Yu; Yan Jin; Xaingning Meng; Donglin Sun; Jing Bai; Feng Chen; Songbin Fu
Journal:  J Genet       Date:  2010-04       Impact factor: 1.166

2.  Impact of restricted marital practices on genetic variation in an endogamous Gujarati group.

Authors:  Trevor J Pemberton; Fang-Yuan Li; Erin K Hanson; Niyati U Mehta; Sunju Choi; Jack Ballantyne; John W Belmont; Noah A Rosenberg; Chris Tyler-Smith; Pragna I Patel
Journal:  Am J Phys Anthropol       Date:  2012-06-23       Impact factor: 2.868

Review 3.  Forensic use of Y-chromosome DNA: a general overview.

Authors:  Manfred Kayser
Journal:  Hum Genet       Date:  2017-03-17       Impact factor: 4.132

4.  Improved resolution haplogroup G phylogeny in the Y chromosome, revealed by a set of newly characterized SNPs.

Authors:  Lynn M Sims; Dennis Garvey; Jack Ballantyne
Journal:  PLoS One       Date:  2009-06-04       Impact factor: 3.240

5.  Isolating DNA from sexual assault cases: a comparison of standard methods with a nuclease-based approach.

Authors:  Alex M Garvin; Andrea Fischer; Jutta Schnee-Griese; Andrea Jelinski; Michel Bottinelli; Gianni Soldati; Monica Tubio; Vincent Castella; Nathalie Monney; Naseem Malik; Michelle Madrid
Journal:  Investig Genet       Date:  2012-12-04

6.  An ultra-high discrimination Y chromosome short tandem repeat multiplex DNA typing system.

Authors:  Erin K Hanson; Jack Ballantyne
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.